期刊文献+

丙型病毒性肝炎治疗的决策和选择 被引量:13

原文传递
导出
作者 姚光弼
出处 《中华传染病杂志》 CAS CSCD 北大核心 2003年第6期381-385,共5页 Chinese Journal of Infectious Diseases
  • 相关文献

参考文献14

  • 1Alberti A;Benvegnu L.Management of hepatitis C[J],2003.
  • 2Seef LB;Hoofnagle JH.National Institutes of Health consensus development management of hepatitis C:2002,2002.
  • 3Manns MP;McHutchison JG;Gordon S.Peginterferm al fa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C,A randomized trial[J],2002(9286).
  • 4Fried MW;Shiffman ML;Reddy KR.Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection[J]New England Journal of Medicine,2002(13):975-982.
  • 5HADZIYANNIS SJ;Cheinquer H;Morgan T.Peg-interferon alfa-2a(40KD)(Pegasys) in combination with ribavirin:Efficacy and safety results from a phase Ⅲ,randomized,double-blind,multicentre study examining the effect of duration of treatment and ribavirin dose (abstract),2002(37).
  • 6Karnam US;Reddy KR.Pegyated interferons[J],2003(1).
  • 7McHutchison JG;Fried MW.Current therrpy for hepatitis C: Pegylated interferon and ribavirin[J],2003(1).
  • 8DiBisceglie AM;Hoofnagle JH.Optimal therapy of hepatitis C[J],2002.
  • 9Chander G;Sulkowski MS;Jonckes MW.Treatment of Chronic hepatitis C:A Systematic review,2002.
  • 10Pawlotsky JM.Use and interpretation of hepatitis C virus diagnostic assay[J],2003(1).

共引文献3

同被引文献101

引证文献13

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部